B-Cell-Derived TGF-β1 Inhibits Osteogenesis and Contributes to Bone Loss in Periodontitis.

Area of Science:

• Immunology
• Periodontology
• Stem Cell Biology

Background:

• B cells are crucial in periodontal disease, influencing pathogen elimination and immune response.
• The specific role of B cells in mesenchymal stem cell (MSC) differentiation dysfunction during periodontitis (PD) remains unclear.

Purpose of the Study:

• To investigate the impact of B cells on MSC differentiation into osteoblasts in periodontitis.
• To elucidate the mechanisms by which B cells contribute to alveolar bone loss in PD.

Main Methods:

• Analysis of MSC and B cell populations in human periodontal tissues.
• Utilizing a murine model of ligature-induced periodontitis with B cell depletion and genetic manipulation.
• Assessing osteoblast differentiation markers (ALP, Runx2) and osteoclast activity (TRAP).
• Investigating the role of TGF-β1 signaling pathway (p-Smad2/3).

Main Results:

• Mesenchymal stem cells (MSCs) were significantly reduced in inflamed periodontal tissues of PD patients.
• B cells, especially memory B cells, dominated immune infiltrates in PD tissues.
• B cell depletion or TGF-β1 neutralization reduced alveolar bone loss in a murine PD model.
• B cells from PD mice inhibited osteoblast differentiation via TGF-β1, upregulating p-Smad2/3 and downregulating Runx2.
• B cell-specific knockout of TGF-β1 in PD mice preserved MSCs, enhanced osteoblast activity, and increased bone volume while reducing osteoclast activity.

Conclusions:

• TGF-β1 produced by B cells, particularly memory B cells, plays a significant role in suppressing osteoblast differentiation.
• B cell-mediated TGF-β1 production contributes to alveolar bone loss in periodontitis.
• Targeting B cells or TGF-β1 may offer therapeutic strategies for periodontitis.